CMP as on 06-Jul-22 15:29
₹ 2,709.90Open
₹ 2,655.00Turnover (lac)
₹ 3,561Prev. Close
₹ 2,646.05Day's Vol (shares)
₹ 1,31,390CMP as on06-Jul-22 15:29
₹ 2,715.25Open
₹ 2,680.00Turnover (lac)
₹ 62Prev. Close
₹ 2,644.95Day's Vol (shares)
₹ 1,918CMP as on 06-Jul-22 0:00
₹ 2,710.15Open
₹ 2,654.75Open Interest(Contracts)
₹ 17,90,250VWAP
₹ 2,690.90Day's Vol (shares)
₹ 1,39,000The new product caters to domestic market.
The company reported consolidated revenue of Rs 1,356.30 crore for Q3 FY22 as against Rs 1,162.10 crore for Q3 FY21, up by 16.71% YoY.
The agreements are for undertaking the business of manufacturing and selling the products for Bio-Chemistry processes and Bio-Chemical
PI Health Sciences Limited has an authorized share capital of Rs1cr divided into 10 lakh equity shares of Rs10/- each.
In the Nifty Next 50 index, the committee excluded five stocks. These are Abbott India, Alkem Lab, MRF, Petronet LNG and United Breweri
The ratings continue to reflect PIs growing presence in the CSM business.
Viswanathan took charge as CFO of the company effective from August 01, 2021.
Dr. KVS Ram Rao joined PI in November, 2018 as CEO CSM Export.
The company has reported a 39.98% yoy rise in consolidated sales revenues for the Mar-21 quarter at Rs1,197.10cr.
The market lot, scheme of strikes and quantity freeze limit of the mentioned securities shall be informed to members on February 25, 20
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity